The Pseudomonas Aeruginosa Bacterial Load Test is a specialized diagnostic procedure aimed at detecting and quantifying the presence of Pseudomonas aeruginosa, a common bacterium that can cause a range of infections, particularly in individuals with weakened immune systems or in hospital settings. This test is crucial for identifying infections associated with this bacterium, which is known for its resistance to antibiotics and its role in various hospital-acquired infections, including pneumonia, urinary tract infections, and sepsis.
Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test utilizes advanced molecular techniques to accurately determine the bacterial load of Pseudomonas aeruginosa in a sample. This information is vital for clinicians to make informed decisions regarding the appropriate treatment strategies, especially in managing infections in critical care settings or in patients with chronic conditions that make them more susceptible to infections.
The cost of the Pseudomonas Aeruginosa Bacterial Load Test at DNA Labs UAE is set at 1360 AED. This price reflects the sophisticated technology and expertise required to perform the test and provide reliable, timely results. Patients and healthcare providers opting for this test at DNA Labs UAE can expect high-quality service and accurate diagnostic information, which is essential for effective infection management and control.
The "Salmonella Typhi Bacterial Load Test" is a diagnostic procedure designed to detect and quantify the presence of Salmonella Typhi bacteria in the body, the causative agent of typhoid fever. This test is particularly crucial for diagnosing individuals who exhibit symptoms of typhoid fever, such as prolonged fever, fatigue, headache, nausea, abdominal pain, and constipation or diarrhea. Early detection and quantification of the bacterial load can significantly influence the management and treatment of the infection, helping to monitor the effectiveness of antibiotics and guide treatment decisions.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic technologies and expertise, the test ensures high sensitivity and specificity in detecting the Salmonella Typhi bacteria. The cost of the test is 1360 AED, reflecting the comprehensive approach and the sophisticated methodologies employed to achieve accurate and reliable results. This test is an essential tool in the public health arsenal against typhoid fever, aiding in the prompt treatment of affected individuals and helping to prevent the spread of this potentially life-threatening infection.
The "Shigella Dysenteriae Bacterial Load Test" is a diagnostic assay designed to detect and quantify the presence of Shigella dysenteriae, a bacterium responsible for causing severe dysentery, particularly in developing countries. This bacterium is known for its rapid transmission and significant health impact, leading to symptoms ranging from mild abdominal discomfort to severe, life-threatening dehydration and intestinal damage. The test typically involves analyzing a stool sample to identify the bacterial DNA, ensuring a high level of accuracy in diagnosing infections.
Performed at DNA Labs UAE, a leading facility in the region for genetic and microbiological testing, the test leverages state-of-the-art technology to ensure reliable results. With a cost of 1360 AED, the test is accessible to those who suspect they might be suffering from an infection caused by Shigella dysenteriae, providing them with crucial information for appropriate treatment and management of the condition. DNA Labs UAE is known for its commitment to quality and accuracy, making it a trusted choice for patients and healthcare providers seeking comprehensive diagnostic solutions.
The Toxoplasma Gondii Bacterial Load Test is a specialized diagnostic procedure aimed at detecting and quantifying the presence of Toxoplasma gondii, a parasitic protozoan that can cause toxoplasmosis in humans. This test is particularly important for pregnant women, individuals with weakened immune systems, and those who have been exposed to the parasite through contact with cat feces or consumption of undercooked meat. The test involves analyzing a sample of the patient's blood or body fluid to determine the level of infection, which is crucial for guiding treatment decisions.
Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, the test ensures high accuracy and reliability. The cost for the Toxoplasma Gondii Bacterial Load Test at DNA Labs UAE is set at 1360 AED. This price reflects the sophisticated nature of the testing technology and the expertise required to accurately interpret the results. Patients opting for this test at DNA Labs UAE can expect professional service, detailed results, and comprehensive support in understanding their condition and the necessary steps to manage or treat the infection.
Chromosome Analysis Products of Conception Reflex Testing to FISH for Aneuploidy Detection is a specialized diagnostic test offered by DNA Labs UAE, designed to evaluate genetic abnormalities in fetal tissue following a miscarriage. This comprehensive analysis begins with a standard chromosome study to assess the genetic material of the products of conception. If initial findings suggest the need for further investigation, the test reflexively progresses to Fluorescence In Situ Hybridization (FISH), a more targeted approach that specifically looks for aneuploidies - abnormalities in the number of chromosomes, which are common causes of pregnancy loss.
The FISH technique enables rapid and precise identification of aneuploidies involving the most clinically significant chromosomes (13, 18, 21, X, and Y), providing crucial information for understanding the genetic factors contributing to the miscarriage. This information can be invaluable for genetic counseling, helping parents understand their future pregnancy risks and options.
The cost of this thorough and sensitive testing process is 1360 AED. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test ensures high-quality, reliable results, offering essential insights for couples seeking answers in the face of pregnancy loss.
The Coccidioides Antibody Test is a medical diagnostic tool used to detect antibodies against the Coccidioides fungus in the blood. This fungus is responsible for causing coccidioidomycosis, also known as Valley Fever, a disease that primarily affects the lungs and can manifest in flu-like symptoms, including cough, fever, and fatigue. In more severe cases, it can spread beyond the lungs and affect other parts of the body. The test is particularly valuable for individuals residing in or having traveled to areas where the fungus is endemic, such as certain parts of the United States, Mexico, Central, and South America.
At DNA Labs UAE, the test is available for a cost of 1430 AED. The facility ensures accurate and reliable results, employing advanced diagnostic techniques to detect the presence of Coccidioides antibodies. Conducted in a state-of-the-art laboratory by experienced professionals, the test is crucial for the timely diagnosis and management of coccidioidomycosis. Early detection through the Coccidioides Antibody Test can significantly improve treatment outcomes by allowing healthcare providers to initiate appropriate therapeutic interventions promptly.
The Ganglioside GD1a Antibody IgG Test is a specialized diagnostic procedure designed to detect the presence of IgG antibodies against the ganglioside GD1a in the blood. Gangliosides are complex glycosphingolipids found in the cell membranes, particularly within the nervous system, and play a critical role in cell-to-cell communication and neurodevelopment. The presence of antibodies against ganglioside GD1a can be indicative of autoimmune neuropathies, such as Guillain-Barré Syndrome (GBS) and its variants, where the body's immune system mistakenly attacks the peripheral nerves.
Conducted at DNA Labs UAE, a reputable facility known for its comprehensive range of diagnostic services, this test is performed under stringent quality control measures to ensure accuracy and reliability of results. The cost of the Ganglioside GD1a Antibody IgG Test is set at 1420 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed in detecting these specific antibodies. This test is crucial for individuals exhibiting symptoms of neuropathy or muscle weakness, as it aids in the diagnosis and subsequent management of autoimmune neurological disorders, ensuring timely and appropriate intervention.
The Ganglioside GD1b Antibody IgG Test is a specialized blood test designed to detect the presence of IgG antibodies against ganglioside GD1b in the bloodstream. Gangliosides are complex glycosphingolipids that play critical roles in cell-to-cell communication and are abundant in the nervous system. The presence of antibodies against ganglioside GD1b can be associated with various neurological disorders, including Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and other neuropathies.
This test is crucial for diagnosing and managing patients with suspected autoimmune neuropathies. By identifying the specific antibodies, healthcare providers can better understand the nature of the neuropathy, leading to more targeted and effective treatment plans.
In the United Arab Emirates, this test is available at DNA Labs UAE, a leading diagnostic center known for its comprehensive range of tests and advanced laboratory technologies. The cost of the Ganglioside GD1b Antibody IgG Test at DNA Labs UAE is 1420 AED. Patients or healthcare providers looking to conduct this test can expect state-of-the-art facilities and professional services, ensuring accurate and reliable results.
The C6 Complement Test is a specialized diagnostic procedure designed to measure the levels of the C6 protein in the blood. C6 is a crucial component of the complement system, which plays a vital role in the immune system by helping to clear pathogens from the body. Abnormal levels of C6 can indicate issues with the complement system, which may be related to a variety of conditions, including autoimmune diseases, recurrent bacterial infections, and certain types of kidney diseases.
The test involves drawing a blood sample from the patient, which is then analyzed in a laboratory to determine the concentration of C6 protein. It is a valuable tool for clinicians in diagnosing and managing conditions related to the complement system.
In the United Arab Emirates, the C6 Complement Test can be conducted at DNA Labs UAE, a leading facility known for its state-of-the-art testing services. The cost of the test at DNA Labs UAE is 1420 AED. This facility is equipped with advanced diagnostic technologies and staffed by experienced professionals, ensuring accurate and reliable test results. Patients choosing DNA Labs UAE for their C6 Complement Test can expect a high standard of service and care throughout the testing process.
The BCR-ABL Quantitative MRD (Minimal Residual Disease) Monitor Test is a sophisticated diagnostic procedure employed to measure the amount of BCR-ABL fusion gene transcripts present in the blood or bone marrow of patients who have been diagnosed with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL). This test is crucial for evaluating the effectiveness of therapy, predicting relapse, and guiding treatment decisions in individuals undergoing treatment for these types of leukemia.
Performed at DNA Labs UAE, a leading diagnostic facility, the test leverages advanced molecular techniques to provide accurate and sensitive detection of minimal residual disease, offering valuable insights into the patient's response to treatment and disease progression. The cost of the BCR-ABL Quantitative MRD Monitor Test at DNA Labs UAE is set at 1400 AED, reflecting the comprehensive approach and cutting-edge technology utilized in this critical assessment. This test plays a pivotal role in personalized medicine, enabling healthcare providers to tailor treatment strategies based on the patient's specific disease dynamics and response to therapy.